A research team led by neuroscientist Dominik Paquet has built a three-dimensional model of human brain tissue designed to reproduce the cellular interactions that drive Alzheimer's disease, with the results published in the journal Nature Neuroscience. Paquet says the model took nine years to develop before it worked at all the levels his group considered necessary.
The gap the work aims to fill is a longstanding one. Despite decades of intensive research worldwide and recent therapeutic advances, no treatment has fully halted the progression of Alzheimer's. Paquet points to a missing tool: three-dimensional models that accurately replicate the complex interactions found in human brain tissue affected by the disease. Grown from stem cells, the new tissue model is an attempt to supply exactly that.
Notably, the team's priority was not architectural fidelity. For Alzheimer's research, Paquet argues, what matters most is how different cell types interact and how their biochemical functions play out - considerably more than a precise structural copy of the brain. That framing shapes what such a model can be used for: probing disease mechanisms in human cells and screening candidate compounds in a setting closer to real brain tissue than flat cell cultures allow.
If the model holds up in wider use, the practical payoff would be in drug development, where promising Alzheimer's candidates have repeatedly failed to translate from the lab. A human tissue system that captures cell-to-cell interplay could help researchers spot which approaches are worth pursuing earlier, though that promise still has to be demonstrated across many laboratories and drug programs.